{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:53:11Z","timestamp":1781855591713,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.pcd.2025.12.005","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T12:31:24Z","timestamp":1766493084000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative risk of osteoporosis in older women with type 2 diabetes receiving sodium\u2013glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 inhibitor: A nationwide cohort study"],"prefix":"10.1016","volume":"20","author":[{"given":"Hyeon Jeong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7349-9880","authenticated-orcid":false,"given":"Pusoon","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2025.12.005_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2025.12.005_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fendo.2019.00045","article-title":"Diabetes and aging: from treatment goals to pharmacologic therapy","volume":"10","author":"Longo","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.pcd.2025.12.005_bib3","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"P.D. Delmas. Bone quality--the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.pcd.2025.12.005_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20132020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr. Pr."},{"key":"10.1016\/j.pcd.2025.12.005_bib5","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.2337\/dc25-S004","article-title":"American Diabetes Association Professional Practice Committee. Comprehensive medical evaluation and assessment of comorbidities: Standards of Care in Diabetes\u20132025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2025.12.005_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/dom.13018","article-title":"Do we know the true mechanism of action of the DPP-4 inhibitors?","volume":"20","author":"Andersen","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2025.12.005_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2023.101455","article-title":"Meta-analysis on the association between DPP-4 inhibitors and bone mineral density and osteoporosis","volume":"27","author":"Huang","year":"2024","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.pcd.2025.12.005_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fphar.2017.00487","article-title":"Effect of dipeptidyl peptidase-4 inhibitors on bone metabolism and the possible underlying mechanisms","volume":"8","author":"Yang","year":"2017","journal-title":"Front. Pharm."},{"key":"10.1016\/j.pcd.2025.12.005_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.918350","article-title":"The extraglycemic effect of SGLT-2is on mineral and bone metabolism and bone fracture","volume":"13","author":"Dong","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.pcd.2025.12.005_bib10","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3389\/fphar.2018.01517","article-title":"Effect of sodium-glucose co-transporter 2 inhibitors on bone metabolism and fracture risk","volume":"9","author":"Ye","year":"2019","journal-title":"Front Pharm."},{"key":"10.1016\/j.pcd.2025.12.005_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12902-024-01575-8","article-title":"Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.pcd.2025.12.005_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3170","article-title":"Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes: an updated meta-analysis","volume":"35","author":"Li","year":"2019","journal-title":"Diabetes Metab. Res."},{"key":"10.1016\/j.pcd.2025.12.005_bib13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/dom.14261","article-title":"Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a nationwide population-based study","volume":"23","author":"Han","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2025.12.005_bib14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/jdi.13768","article-title":"Sodium-glucose cotransporter 2 inhibitors do not increase the risk of fractures in real-world clinical practice in Korea: a national observational cohort study","volume":"13","author":"Ha","year":"2022","journal-title":"J. Diabetes Invest."},{"key":"10.1016\/j.pcd.2025.12.005_bib15","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1111\/dom.15220","article-title":"The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus","volume":"25","author":"van Hulten","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2025.12.005_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101465","article-title":"Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: a nationwide retrospective cohort study","volume":"49","author":"Peng","year":"2023","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.pcd.2025.12.005_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mayocp.2014.09.011","article-title":"Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States","volume":"90","author":"Singer","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.pcd.2025.12.005_bib18","unstructured":"KOICD. Disease Statistics. Accessed December 26, 2024. https:\/\/www.koicd.kr\/stt\/statDisease.do#."},{"key":"10.1016\/j.pcd.2025.12.005_bib19","unstructured":"HIRA Bigdata Open portal. Medical statistics information. Accessed December 26, 2024. https:\/\/opendata.hira.or.kr\/op\/opc\/olap3thDsInfoTab2.do."},{"key":"10.1016\/j.pcd.2025.12.005_bib20","doi-asserted-by":"crossref","DOI":"10.4178\/epih\/e2014008","article-title":"A guide for the utilization of health insurance review and assessment service national patient samples","volume":"36","author":"Kim","year":"2014","journal-title":"Epidemiol. Health"},{"key":"10.1016\/j.pcd.2025.12.005_bib21","unstructured":"Health Insurance Review & Assessment Service. HIRA Research data user guide. Accessed December 26, 2024. file:\/\/\/C:\/Users\/admin\/Downloads\/%EC%97%B0%EA%B5%AC%EA%B3%BC%EC%A0%9C%20%EC%9D%B4%EC%9A%A9%20%EA%B0%80%EC%9D%B4%EB%93%9C%20(11).pdf."},{"key":"10.1016\/j.pcd.2025.12.005_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/medicina60030393","article-title":"Effect of drugs used in pharmacotherapy of type 2 diabetes on bone density and risk of bone fractures","volume":"60","author":"Wikarek","year":"2024","journal-title":"Medicina"},{"key":"10.1016\/j.pcd.2025.12.005_bib23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.pcd.2025.12.005_bib24","unstructured":"The Korean Society for Bone and Mineral Research. 2024 Guidelines for the diagnosis and management of osteoporosis. Accessed December 26, 2024. https:\/\/www.ksbmr.org\/bbs\/?number=1672&mode=view&code=notice."},{"key":"10.1016\/j.pcd.2025.12.005_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/aje\/kwj047","article-title":"Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect","volume":"163","author":"Kurth","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.pcd.2025.12.005_bib26","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219801120","article-title":"Surfaceome analysis of extracellular vesicles from senescent cells uncovers uptake repressor DPP4","volume":"120","author":"Meng","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pcd.2025.12.005_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165933","article-title":"DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice","volume":"133","author":"Herman","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pcd.2025.12.005_bib28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s43587-024-00642-y","article-title":"SGLT2 inhibition eliminates senescent cells and alleviates pathological aging","volume":"4","author":"Katsuumi","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.pcd.2025.12.005_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.30762","article-title":"Association of sodium-glucose cotransporter-2 inhibitors with fracture risk in older adults with type 2 diabetes","volume":"4","author":"Zhuo","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.pcd.2025.12.005_bib30","first-page":"783","article-title":"How do Korean women manage menstrual or menopausal symptoms: 2022 women\u2019s health survey for sexual and reproductive health","volume":"16","author":"Song","year":"2023","journal-title":"Public Health Wkly. Rep."},{"key":"10.1016\/j.pcd.2025.12.005_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jc.2015-1860","article-title":"Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pcd.2025.12.005_bib32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13300-019-0577-7","article-title":"Characteristics of patients with diabetes initiating sodium glucose co-transporter-2 inhibitors (SGLT2i): real-world results from three administrative databases in Japan","volume":"10","author":"Ito","year":"2019","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.pcd.2025.12.005_bib33","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/cells14090668","article-title":"Expanding the use of SGLT2 inhibitors in T2D patients across clinical settings","volume":"14","author":"Cuttone","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.pcd.2025.12.005_bib34","first-page":"1","article-title":"SGLT2 inhibitors in older adults with cardiovascular disease: a systematic review and meta-analysis","author":"Minami","year":"2025","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.pcd.2025.12.005_bib35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s40520-025-03156-8","article-title":"The use of SGLT2 inhibitors in older people: What is important?","volume":"37","author":"Armentaro","year":"2025","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.pcd.2025.12.005_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ageing\/afad254","article-title":"Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis","volume":"53","author":"Aldafas","year":"2024","journal-title":"Age Ageing"},{"key":"10.1016\/j.pcd.2025.12.005_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101419","article-title":"Efficacy and safety profile of SGLT2 inhibitors in the elderly: how is the benefit\/risk balance?","volume":"49","author":"Scheen","year":"2023","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.pcd.2025.12.005_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106396","article-title":"SGLT2-inhibitors are effective and safe in the elderly: The SOLD study","volume":"183","author":"Lunati","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.pcd.2025.12.005_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11657-024-01466-4","article-title":"Osteoporosis incidence and its associated factors in the older Korean population: findings from a population-based cohort study","volume":"19","author":"Das","year":"2024","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.pcd.2025.12.005_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2024.112614","article-title":"The interplay between osteoarthritis and osteoporosis: mechanisms, implications, and treatment considerations - a narrative review","volume":"197","author":"Huang","year":"2024","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.pcd.2025.12.005_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/crj.70086","article-title":"Dose of inhaled corticosteroid in chronic obstructive pulmonary disease and risks of osteoporosis or fracture-a systematic review and meta-analysis","volume":"19","author":"Kwok","year":"2025","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.pcd.2025.12.005_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111781","article-title":"Profiles of sulfonylurea use in diabetes mellitus type 2: an analysis of clinical practice over the last 10 years","volume":"214","author":"Baccetti","year":"2024","journal-title":"Diabetes Res. Clin. Pr."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991825002359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991825002359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:20:40Z","timestamp":1781853640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991825002359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1751991825002359"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2025.12.005","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative risk of osteoporosis in older women with type 2 diabetes receiving sodium\u2013glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 inhibitor: A nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2025.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}